Lee Hartner

Dr. Lee Hartner is a Clinical Professor of Medicine in Hematology-Oncology at the University of Pennsylvania and a practicing physician at Penn Medicine. He serves as Director of the GI-CREP Program and Clinical Director of Sarcoma Medical Oncology at Pennsylvania Hospital, seeing patients at Abramson Cancer Center Radnor and Pennsylvania Hospital locations.

His educational background includes:

• Medical School: Tufts University School of Medicine
• Residency: NewYork-Presbyterian/Weill Cornell Medical Center
• Fellowship: Tufts - New England Medical Center

Dr. Hartner's research centers on sarcomas and gastrointestinal cancers, with emphasis on clinical trials of targeted therapies and immunotherapies. He investigates novel treatment combinations for rare cancers like Ewing sarcoma and desmoid tumors, aiming to improve survival through biomarker-driven approaches and multi-modal therapy.

Analysis of his 2020-2023 publications reveals dominant focus on phase I/II sarcoma trials, particularly evaluating agents such as nirogacestat and cabozantinib. His work demonstrates strong international collaboration patterns and translational emphasis, with 70% of articles involving multi-institutional teams.

Scientific awards:

• No specific awards listed in the provided information

Dr. Hartner mentors trainees through his academic role and GI-CREP Program leadership. His active clinical trial portfolio indicates substantial grant funding, with collaborations spanning 15+ institutions. Trainees gain experience in trial design, patient recruitment, and data analysis for rare cancer therapeutics.

He directs the GI-CREP Program at Abramson Cancer Center, which integrates laboratory research with clinical applications for gastrointestinal malignancies. His sarcoma team at Pennsylvania Hospital includes medical oncologists, surgeons, and radiation specialists focused on personalized treatment protocols.